Stocks · Health care · Pharmaceutical Preparations

Akebia Therapeutics, Inc.

AKBA Clue Score38
United States Fiscal year ends December CIK 0001517022 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
John P. Butler
4 Mar 2026
CEO and President
Buy
69,270
$1.25
$86.59K

What was left out

Form 4 filings counted 22
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,363,450
History held since 26 Mar 2014